Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

761 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Miehlke S, Kirsch C, Schneider-Brachert W, Haferland C, Neumeyer M, Bästlein E, Papke J, Jacobs E, Vieth M, Stolte M, Lehn N, Bayerdörffer E. Miehlke S, et al. Among authors: stolte m. Helicobacter. 2003 Aug;8(4):310-9. doi: 10.1046/j.1523-5378.2003.00158.x. Helicobacter. 2003. PMID: 12950604 Clinical Trial.
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
Antos D, Schneider-Brachert W, Bästlein E, Hänel C, Haferland C, Buchner M, Meier E, Trump F, Stolte M, Lehn N, Bayerdörffer E. Antos D, et al. Among authors: stolte m. Helicobacter. 2006 Feb;11(1):39-45. doi: 10.1111/j.0083-8703.2006.00375.x. Helicobacter. 2006. PMID: 16423088 Clinical Trial.
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.
Miehlke S, Schneider-Brachert W, Kirsch C, Morgner A, Madisch A, Kuhlisch E, Haferland C, Bästlein E, Jebens C, Zekorn C, Knoth H, Stolte M, Lehn N. Miehlke S, et al. Among authors: stolte m. Helicobacter. 2008 Feb;13(1):69-74. doi: 10.1111/j.1523-5378.2007.00588.x. Helicobacter. 2008. PMID: 18205669 Clinical Trial.
Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.
Miehlke S, Krasz S, Schneider-Brachert W, Kuhlisch E, Berning M, Madisch A, Laass MW, Neumeyer M, Jebens C, Zekorn C, Knoth H, Vieth M, Stolte M, Lehn N, Morgner A. Miehlke S, et al. Among authors: stolte m. Helicobacter. 2011 Dec;16(6):420-6. doi: 10.1111/j.1523-5378.2011.00867.x. Helicobacter. 2011. PMID: 22059392 Clinical Trial.
Oral budesonide therapy improves quality of life in patients with collagenous colitis.
Madisch A, Heymer P, Voss C, Wigginghaus B, Bästlein E, Bayerdörffer E, Meier E, Schimming W, Bethke B, Stolte M, Miehlke S. Madisch A, et al. Among authors: stolte m. Int J Colorectal Dis. 2005 Jul;20(4):312-6. doi: 10.1007/s00384-004-0660-y. Epub 2004 Nov 11. Int J Colorectal Dis. 2005. PMID: 15549326 Clinical Trial.
761 results